|
|
Article: Ramelteon is effective for some insomnia patients.(Psychosomatic Medicine)
- Article from:
- Clinical Psychiatry News
- Article date:
- February 1, 2007
- Author:
-
|
Copyright informationCOPYRIGHT 2007 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ORLANDO -- Ramelteon is effective for a subset of patients with insomnia, according to a presentation at a psychopharmacology congress sponsored by the Neuroscience Education Institute. In addition, because the agent works on melatonin receptors, a potential off-label use is for patients with shift-work disorder.
Ramelteon (Rozerem, Takeda Pharmaceuticals) targets the melatonin receptors MT1 and MT2. The agent is approximately 10 times more potent than melatonin. Other approved drugs promote sleep by increasing [gamma]-aminobutyric acid (GABA), which is normally released by the suprachiasmatic nucleus in the brain.
"Ramelteon is a very interesting drug. It is the first ...
Related newspaper, magazine, and journal articles:
|
|
Article: DR. PIER PACI, AT 58; PATHOLOGIST, HARVARD MEDICAL SCHOOL INSTRUCTOR
The Boston Globe;
February 19, 1989 ;
547 words
...Dr. Pier Franco Paci, a pathologist at Brigham and Women's Hospital...pancreatic cancer Wednesday in his home in Brookline. He was 58. Dr. Paci's accuracy in diagnosing tumors and the gusto, warmth...sad and at a loss for words on seeing the enfeebled honoree. Dr. Paci, irrepressible as ever, blurted out: ...
|
|